PROCEPT BioRobotics Revenue and Competitors
Estimated Revenue & Valuation
- PROCEPT BioRobotics's estimated annual revenue is currently $92.6M per year.
- PROCEPT BioRobotics received $118.0M in venture funding in February 2018.
- PROCEPT BioRobotics's estimated revenue per employee is $313,750
- PROCEPT BioRobotics's total funding is $443.3M.
Employee Data
- PROCEPT BioRobotics has 295 Employees.
- PROCEPT BioRobotics grew their employee count by 26% last year.
PROCEPT BioRobotics Competitors & Alternatives
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $19.6M | 78 | -4% | N/A | N/A |
#2 | $3.5M | 34 | -8% | N/A | N/A |
#3 | $5.5M | 22 | 83% | N/A | N/A |
#4 | $3.3M | 32 | 0% | N/A | N/A |
#5 | $5.8M | 23 | -28% | N/A | N/A |
#6 | $49.7M | 198 | -13% | N/A | N/A |
#7 | $9.8M | 39 | N/A | N/A | N/A |
#8 | $2.9M | 28 | 75% | N/A | N/A |
#9 | $27.4M | 109 | 11% | N/A | N/A |
#10 | $49.3M | 157 | 28% | $199.1M | N/A |
What Is PROCEPT BioRobotics?
Based in Silicon Valley, PROCEPT BioRobotics is a privately held surgical robotics company enabling better patient care by developing transformative solutions in urology. With an initial focus on benign prostatic hyperplasia (BPH), the company's first product, the AQUABEAM System delivering Aquablation therapy, is the world's first commercially available minimally invasive surgical robot providing autonomous tissue removal to safely and effectively treat BPH. Aquablation therapy offers predictable and reproducible outcomes, independent of prostate anatomy or surgeon experience.
keywords:Biotechnology,Healthcare,Medical Devices,Pharmaceuticals
$443.3M
Total Funding
295
Number of Employees
$92.6M
Revenue (est)
26%
Employee Growth %
N/A
Valuation
N/A
Accelerator
PROCEPT BioRobotics News
PROCEPT BioRobotics Corp. Announces Investor Event at 2022 AUA Annual Meeting in New Orleans. PROCEPT BioRobotics (GLOBE NEWSWIRE)...
PROCEPT BioRobotics Corp. to Report First Quarter 2022 Financial Results on May 5, 2022 and attend the 2022 Bank of America Healthcare...
REDWOOD CITY, Calif., April 11, 2022 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT), a surgical robotics company focused...
REDWOOD CITY, Calif., Nov. 04, 2021 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported financial results for the quarter ended September 30, 2021. Re ...
Other Companies in Redwood Shores
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $76.1M | 420 | N/A | N/A |
#2 | $439.5M | 1495 | 7% | N/A |
#3 | $4245.1M | 20912 | N/A | N/A |
PROCEPT BioRobotics Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2015-07-08 | $42.0M | Undisclosed | Novo A/S | Article |
| 2015-07-21 | $7.7M | Undisclosed | Article | |
| 2018-02-22 | $118.0M | Undisclosed | Viking Global Investors LP | Article |
